Orchid Island Capital (ORC) director granted 7,169 DSUs
Ava L. Parker, a director of Orchid Island Capital, Inc. (ORC), reported three grants of deferred stock units on 09/30/2025 and 10/01/2025.
Rhea-AI Filing Summary
Ava L. Parker, a director of Orchid Island Capital, Inc. (ORC), reported three grants of deferred stock units on 09/30/2025 and 10/01/2025.
The filings show 1,553 DSUs issued on 09/30/2025 in lieu of the monthly dividend at an attributable value of $6.91 per unit, plus two grants on 10/01/2025 of 3,566 DSUs (no price listed) and 2,050 DSUs granted in lieu of cash compensation with an attributable value of $7.01 per unit. Following these transactions the reporting person beneficially owned 96,636 shares.
The DSUs are fully vested but payable only upon a change of control or the reporting person's death, disability, or separation from service as a director.
Positive
- 7,169 deferred stock units granted, aligning director compensation with shareholder equity
- DSUs are 100% vested, indicating no further service requirement to earn these awards
Negative
- Deferred payout triggers (change of control, death, disability, separation) delay share issuance and liquidity
- One grant of 3,566 DSUs lacks an attributable per-unit price in the table, reducing transparency
Insights
Director received vested deferred stock units totaling 7,169 DSUs, payable on specific events.
The Form 4 discloses three DSU grants totaling 7,169 units (1,553 + 3,566 + 2,050) issued across 09/30/2025 and 10/01/2025. These awards increase the director's beneficial ownership to 96,636 shares.
The units are 100% vested but are deferred and become payable only upon a change of control, death, disability, or separation from service, which means the awards create retention-aligned compensation rather than immediate liquidity for the director.
Some DSUs were issued in lieu of dividends and cash compensation with stated per-unit values.
The filing explicitly states 1,553 DSUs were issued in lieu of a monthly dividend at a value of $6.91 per unit and 2,050 DSUs were granted in lieu of cash compensation at $7.01 per unit. One grant of 3,566 DSUs shows an acquisition but no per-unit price in the table.
These facts affect dilution and future share issuance timing because each DSU represents one share payable upon the specified triggering events.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock Units | 3,566 | $0.00 | $0.00 |
| Grant/Award | Deferred Stock Units | 2,050 | $7.01 | $14K |
| Grant/Award | Deferred Stock Units | 1,553 | $6.91 | $11K |
Footnotes (4)
- F1. Each deferred stock unit represents a right to receive one share of the Issuer's common stock.
- F2. The reported shares represent deferred stock units issued in lieu of the Issuer's monthly dividend pursuant to the reporting person's election.
- F3. The deferred stock units are 100% vested but do not become payable until the earlier to occur of a change of control or the reporting person's death, disability, or separation from service as a director of the Issuer.
- F4. The reported shares represent deferred stock units granted in lieu of cash compensation.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transactions did the ORC Form 4 filed by Ava L. Parker report?
Are the deferred stock units vested and when are they payable?
Were any DSUs issued in lieu of dividends or cash compensation?
What per-unit values are disclosed for the DSU grants?
AI-generated analysis. How Rhea-AI works. Not financial advice.